
Fin d'année 31 Décembre 2022 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -78.866 | -112.002 | -80.779 | -99.637 | -103.672 | -221.029 | -146.398 |
Return on Equity (%) | 39.391 | 50.884 | 128.728 | -198.204 | 885.352 | 425.13 | 162.664 |
Return on Invested Capital (%) | 34.891 | 36.45 | 124.649 | -223.261 | 645.863 | 465.79 | 176.442 |
Operating Margin (%) | -355.046 | -2866.977 | -801.777 | -2904.207 | -2232.8 | -2732.769 | -978.648 |
Net Profit Margin (%) | -391.67 | -3191.744 | -850.997 | -2904.207 | -2233.3 | -3017.59 | -982.562 |
Book Value Per Share | -1.563 | -1.727 | 3.242 | 0.404 | -0.865 | -0.742 | -1.166 |
Earnings Per Share | -0.308 | -0.755 | -2.895 | -3.328 | -2.219 | -2.617 | -1.46 |
Cash Per Share | 0.771 | 0.69 | 2.99 | 2.343 | 0.818 | 1.022 | 0.234 |
Working Capital Per Share | 0.693 | 0.61 | 2.844 | 0.73 | -0.962 | -0.506 | -1.215 |
Operating Profit Per Share | 0.012 | 0.024 | 0.34 | 0.115 | 0.099 | 0.087 | 0.149 |
EBIT Per Share | -0.291 | -0.678 | -2.727 | -3.328 | -2.219 | -2.384 | -1.46 |
EBITDA Per Share | -0.291 | -0.678 | -2.727 | -3.328 | -2.219 | -2.384 | -1.46 |
Free Cash Flow Per Share | -0.308 | -0.737 | -2.846 | -3.347 | -2.216 | -2.611 | -1.479 |
Fin d'année 31 Décembre 2022 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 166k | 166k | 8,11M | 8,92M | 10,07M | 17,7M | N/A |
Fin d'année 31 Décembre 2022 | Déc 2021 | Mar 2022 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 17,7M | N/A | N/A | N/A | N/A | N/A | 36,08M | 44,57M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -633.361 | N/A | N/A | N/A | -629.945 | N/A | N/A |
Net Profit Margin (%) | N/A | -654.254 | N/A | N/A | N/A | -629.945 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 12,88M |
Ratio cours/bénéfice | 0 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 0 |
Rendement de dividende | - |
Actions en circulation | 44,57M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales